Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature

Clicks: 196
ID: 272090
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the mainstream route of drug administration to the posterior segment of the eye. The purpose of this review is to assess th …
Reference Key
c2020pharmaceuticsintravitreal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Iovino C;Mastropasqua R;Lupidi M;Bacherini D;Pellegrini M;Bernabei F;Borrelli E;Sacconi R;Carnevali A;D'Aloisio R;Cerquaglia A;Finocchio L;Govetto A;Erba S;Triolo G;Di Zazzo A;Forlini M;Vagge A;Giannaccare G;;
Journal Pharmaceutics
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32722556/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review pubmed abstract nih national institutes of health national library of medicine pmid:32722556 pmc7466091 doi:10.3390/pharmaceutics12080703 claudio iovino rodolfo mastropasqua giuseppe giannaccare

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.